Why this seasoned money manager sees real upside for this innovative B2B tech startup. on 10/26/2021. Learn More
Change: Change(%):
Volume: Open:
High: Low:
52Wk High: 52Wk Low:

Zynerba Pharmaceuticals is clinical-stage pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments for patients with high unmet medical needs.